Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
FEBS Lett ; 595(22): 2768-2780, 2021 11.
Article in English | MEDLINE | ID: mdl-34652813

ABSTRACT

Nonalcoholic fatty liver disease (NAFLD) is a global health problem that develops through unclear molecular mechanisms. The P2X7 purinergic receptor (P2RX7) is an ATP-gated ion channel that belongs to the P2XR family. Thus far, studies on P2RX7 in NAFLD have been largely contradictory. Integrating experiments and modeling, we elucidate the dynamic processes of lipid droplet fusion and degradation following regulation of P2RX7. We show that activation of P2RX7 can activate the AMPK/ULK1 pathway to promote autophagosome generation and lysosomal degradation of autophagosomes. Inhibiting P2RX7 has the opposite effect. Notably, we find that lipid droplets become larger by the fusion of dysfunctional lysosomes but cannot be degraded by them following P2RX7 inhibition. Our study provides evidence that P2RX7 activation improves NAFLD by promoting lipophagy.


Subject(s)
Autophagy , Lipid Droplets/metabolism , Non-alcoholic Fatty Liver Disease/metabolism , Receptors, Purinergic P2X7/metabolism , AMP-Activated Protein Kinase Kinases/metabolism , Animals , Autophagosomes/metabolism , Autophagy-Related Protein-1 Homolog/metabolism , Hep G2 Cells , Humans , Lysosomes/metabolism , Mice , Mice, Inbred C57BL , Receptors, Purinergic P2X7/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...